• Intercept hits regulatory snag at FDA, likely delaying NASH drug's approval

    11 days ago - By MedCity News

    The company said that the agency had requested additional data for obeticholic acid and thus pushed the upcoming advisory committee meeting back from June 9, thereby delaying its decision on approval, which had also been scheduled for June 26.
    Read more ...